Advisory Research Inc Denali Therapeutics Inc. Transaction History

Advisory Research Inc

  • $512 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$36.89 - $93.56 $1 Million - $2.54 Million
-27,185 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$23.13 - $38.84 $230,166 - $386,496
-9,951 Reduced 26.8%
27,185 $974,000
Q2 2020

Aug 13, 2020
BUY
$16.01 - $28.82 $213,893 - $385,035
13,360 Added 56.19%
37,136 $898,000
Q1 2020

May 12, 2020
BUY
$14.2 - $27.98 $337,619 - $665,252
23,776 New
23,776 $416,000

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email